HTA226 Can Prior Indirect Treatment Comparisons (ITCs) Inform Health Technology Assessment (HTA) Strategy: A Case Study in Relapsed-Refractory Diffuse Large B Cell Lymphoma (RR-DLBCL)
| Title: | HTA226 Can Prior Indirect Treatment Comparisons (ITCs) Inform Health Technology Assessment (HTA) Strategy: A Case Study in Relapsed-Refractory Diffuse Large B Cell Lymphoma (RR-DLBCL) |
|---|---|
| Authors: | Forsythe, A.; Heeg, B.; Tordoff-Gibson, C.; Springford, A. |
| Source: | Value in Health ; volume 26, issue 12, page S363 ; ISSN 1098-3015 |
| Publisher Information: | Elsevier BV |
| Publication Year: | 2023 |
| Collection: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: | article in journal/newspaper |
| Language: | English |
| DOI: | 10.1016/j.jval.2023.09.1909 |
| Availability: | http://dx.doi.org/10.1016/j.jval.2023.09.1909; https://api.elsevier.com/content/article/PII:S1098301523050398?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S1098301523050398?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: | edsbas.E4EACD3B |
| Database: | BASE |